BD Diagnostics EN

Molecular Diagnostics
BD MAX System
BD MAX Instrument
Cat. Nº. SIZE DESCRIPTION
441916 1 BD MAX System
BD MAX is the first fully automated open platform for real-time DNA
amplification assays. All steps - sample processing, PCR setup and
amplification/detection - are integrated into a compact bench top unit that
allows the implementation of multiple assay formats, both commercial and
in-house developed assays. Morever, there are 5 fluorescence channels
available which will allow for direct measurement of multiple targets within
the same sample. The unitized extraction reagents and unique microfluidic
technology simplifies operation to 1 pipetting step and eliminates the
risk of amplifi ed PCR contamination. Capacity is flexible and adaptable
to laboratory demand, from 1 to 24 specimens per run and up to 120
specimens per day.
437519 24
cartridges
BD MAX Microfluidic PCR cartridges
Microfluidic cartridge for RT-PCR incorporates a proprietary design that
allows for rapid amplification and sensitive detection. Each cartridge is build
with 24 independently controlled reaction chambers.
BD MAX Assays
All assays contain strips, master mix, extraction reagents, sample buffer tubes & septum caps provided in
single use format tests. Each test includes specimen process control (SPC) for both the DNA extraction and
PCR reaction.
Cat. Nº. SIZE DESCRIPTION
442953 24 tests BD MAX MRSA - IVD Assay
The BD MAX MRSA Assay performed on the BD MAX System is an
automated qualitative in vitro diagnostic test for the direct detection of
Methicillin-resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in
patients at risk for nasal colonization. The test utilizes real-time polymerase
chain reaction (PCR) for the amplification of MRSA DNA and fluorogenic
target specific hybridization probes for the detection of the amplified DNA.
442555 24 tests BD MAX C difficile - IVD Assay
The BD MAX Cdiff Assay performed on the BD MAX System is an
automated qualitative in vitro diagnostic test for the direct detection of
C. difficile toxin B gene (tcdB) in human liquid or soft stool specimens
from patients suspected of having Clostridium difficile-associated disease
(CDAD). The test utilizes real-time polymerase chain reaction (PCR) for
the amplification of toxin B gene DNA and fluorogenic targets specific
hybridization probes for the detection of the amplified DNA.
158